219 results on '"Thotamgari, Sahith Reddy"'
Search Results
2. Comparative Analysis of Risk Prediction Scores for Treatment-Emergent Atrial Fibrillation Among Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
3. Impact of Atrial Fibrillation on Outcomes in Patients Hospitalized With Nontraumatic Intracerebral Hemorrhage
4. Abstract 15438: Long-Term Outcomes of Bariatric Surgery in Patients With Atrial Fibrillation
5. Abstract 15252: Impact of Atrial Fibrillation on Patients With Carcinoid Syndrome: A National In-Patient Sample Analysis
6. Abstract 14702: The Burden of Cardiac Adverse Events Associated With Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: A Large Pharmacovigilance Database Analysis
7. Abstract 13066: Mortality Differences Between Urban and Rural Hospital Admissions for Left Atrial Appendage Occlusion
8. Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?
9. Impact Of Atrial Fibrillation On Outcomes Of Congestive Heart Failure Patients With Hyponatremia - National Inpatient Sample Analysis
10. Impact Of Sodium Derangements In Patients Hospitalized With Atrial Fibrillation Without Heart Failure: A Nationwide Cohort Study
11. Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging.
12. Financial burden of drugs prescribed for management of atrial fibrillation
13. Impact of Atrial Fibrillation on Patients With Carcinoid Syndrome: A National Inpatient Sample Analysis
14. Safety of catheter ablation for atrial fibrillation in patients with cancer: a nationwide cohort study
15. CE-452776-4 ATRIAL FIBRILLATION IS ASSOCIATED WITH HIGHER INPATIENT MORTALITY AS COMPARED WITH SINUS TACHYCARDIA IN PATIENTS WITH CARDIOGENIC SHOCK
16. AB-452666-1 EFFICACY AND OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH END-STAGE RENAL DISEASE: ANALYSIS OF NATIONWIDE READMISSION DATABASE
17. Impact of body mass index on venous thromboembolism recurrence with direct oral anticoagulants
18. A Comparative Analysis Of Outcomes Of Implantable Cardioverter Defibrillator In Patients With Heart Failure And Left Bundle Branch Block And Right Bundle Branch Morphology
19. Females Have Lower Acute Heart Failure Compared To Males In Patients Who Undergo Catheter Ablation For Atrial Fibrillation: A Nationwide Analysis
20. RACIAL DISPARITIES IN HOSPITALIZATIONS FOR ACUTE HEART FAILURE IN PATIENTS WITH CANCER TREATMENT-RELATED CARDIAC DYSFUNCTION
21. IMPACT OF ACUTE HEART FAILURE ON IN-HOSPITAL OUTCOMES AFTER TRANS-JUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A NATIONWIDE ANALYSIS
22. A REAL-WORLD DISPROPORTIONALITY ANALYSIS OF ATRIAL FIBRILLATION ADVERSE EVENTS ASSOCIATED WITH BISPHOSPHONATES
23. ASSOCIATION OF ATRIAL FIBRILLATION WITH OUTCOMES IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION: A NATIONWIDE ANALYSIS
24. IMPACT OF HYPERTROPHIC CARDIOMYOPATHY ON HOSPITAL OUTCOMES OF PATIENTS WITH ISCHEMIC STROKE: A NATIONAL IN-PATIENT SAMPLE ANALYSIS
25. LONG TERM OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
26. SAFETY OF LEFT ATRIAL APPENDAGE OCCLUSION PROCEDURE IN PATIENTS WITH ATRIAL FIBRILLATION AND COMORBID CANCER
27. LONG TERM OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL FIBRILLATION AND END STAGE RENAL DISEASE: ANALYSIS FROM NATIONWIDE READMISSION DATABASE
28. QUADRICUSPID AORTIC VALVE INFECTIVE ENDOCARDITIS: A RARE ENTITY
29. COVID-19 VERSUS IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS: A CLINICAL DILEMMA
30. COMPARISON OF ADVERSE EVENTS WITH CONTACT FORCE AND NON-CONTACT FORCE ABLATION CATHETERS: A REVIEW OF MAUDE DATABASE
31. IMPACT OF ATRIAL FIBRILLATION ON OUTCOMES IN PATIENTS HOSPITALIZED WITH NON-TRAUMATIC INTRACEREBRAL HEMORRHAGE: INSIGHTS FROM THE NATIONWIDE INPATIENT SAMPLE
32. TRENDS IN SUDDEN CARDIAC DEATH IN YOUNG AND MIDDLE-AGED ADULTS IN THE UNITED STATES FROM 1999-2020
33. Recurrent Venous Thromboembolism with Direct-Acting Oral Anticoagulants and Body Mass Index: A Single Institutional Study
34. Secondary Hemophagocytic Lymphohistiocytosis in Adults: Experience from a Safety Net Hospital Serving an Underserved Population
35. Inpatient Burden, Characteristics and Outcomes Associated with Venous Thrombotic Complications Among Patients with Paroxysmal Nocturnal Hemoglobinuria
36. The association of cardiac arrhythmias with chimeric antigen receptor T cell therapy in hospitalised patients: Insights from National Inpatient Sample
37. Inpatient cardiovascular outcomes in patients with cancer affected by viral influenza infection
38. Real world analysis of cardiac adverse events associated with clozapine: A pharmacovigilance analysis using food and drug administration adverse event reporting system
39. RACIAL DIFFERENCES IN HOSPITALIZATIONS FOR IDIOPATHIC PULMONARY FIBROSIS IN THE UNITED STATES
40. Inpatient cardiovascular outcomes in patients with cancer affected by viral influenza infection.
41. Hospitalized patients are needlessly over-tested for heparin induced thrombocytopenia
42. Liver cirrhosis is independently associated with increased in-hospital mortality in patients undergoing left atrial appendage occlusion device implantation
43. Low left atrial appendage emptying velocity is a predictor of atrial fibrillation recurrence after catheter ablation
44. PO-712-04 FINANCIAL BURDEN OF DRUGS PRESCRIBED FOR MANAGEMENT OF ATRIAL FIBRILLATION
45. PO-685-06 LIVER CIRRHOSIS IS ASSOCIATED WITH AN INCREASE IN BLEEDING AND MORTALITY IN PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE OCCLUSION: INSIGHTS FROM A NATIONWIDE COHORT ANALYSIS
46. PO-640-06 HORMONE REPLACEMENT THERAPY AND AF IN POSTMENOPAUSAL WOMEN: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE (NIS) DATABASE
47. PO-667-08 OUTCOMES AND SAFETY OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH CANCER: A NATIONWIDE ANALYSIS OF 57,730 PROCEDURES
48. CARDIAC ADVERSE EVENTS ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY: A SYSTEMATIC REVIEW
49. RISK OF PERICARDIAL DISEASE WITH RADIATION THERAPY COMPARED TO RISK OF OTHER ADVERSE CARDIOVASCULAR EVENTS (ACE): DATA FROM THE US FDA ADVERSE EVENT REPORTING SYSTEM (FAERS), A PHARMACOVIGILANCE DATABASE.
50. CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IS ASSOCIATED WITH CARDIOMYOPATHY: A NATIONWIDE COHORT ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.